Sanara Medtech Inc. develops and commercializes technologies to improve clinical outcomes and reduce healthcare costs in surgical, chronic wound, and skincare markets. It offers products like CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus, BIASURGE, FORTIFY TRG Tissue Repair Graft, and FORTIFY FLOWABLE Extracellular Matrix for various surgical specialties. These products help promote healing and reduce complications in cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and more. The company also has multiple products in its pipeline. We show 21 historical shares outstanding datapoints in our coverage of SMTI's shares outstanding history.
Understanding the changing numbers of SMTI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like SMTI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching SMTI by allowing them to research SMTI shares outstanding history
as well as any other stock in our coverage universe. |
Free SMTI Email Alerts:
Video: Shares Outstanding Importance
